Acid-responsive HPMA copolymer-bradykinin conjugate enhances tumor-targeted delivery of nanomedicine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Acid-responsive HPMA copolymer-bradykinin conjugate enhances tumor-targeted delivery of nanomedicine

Published:2021-09 Issue: Volume:337 Page:546-556
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Appiah Enoch,Nakamura Hideaki,Pola Robert,Grossmanová Eliška,Lidický Ondřej,Kuniyasu Akihiko,Etrych Tomáš,Haratake Mamoru

Funder

Japan Society for the Promotion of Science

Czech Science Foundation

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference41 articles.

1. Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls;Nakamura;Expert Opin. Drug Deliv.,2015

2. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect;Fang;Adv. Drug Deliv. Rev.,2011

3. Expert Opinion on Drug Delivery Factors affecting the dynamics and heterogeneity of the EPR effect : pathophysiological and pathoanatomic features, drug formulations and physicochemical factors;Islam;Expert Opin. Drug Deliv.,2021

4. Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers;Fang;Adv. Drug Deliv. Rev.,2020

5. Polymer therapeutics and the EPR effect;Maeda;J. Drug Target.,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemical modification of bradykinin-polymer conjugates for optimum delivery of nanomedicines to tumors;Nanomedicine: Nanotechnology, Biology and Medicine;2024-04

2. Stimuli responsiveness of recent biomacromolecular systems (concept to market): A review;International Journal of Biological Macromolecules;2024-03

3. The mechanisms of nanoparticle delivery to solid tumours;Nature Reviews Bioengineering;2024-02-08

4. Nanoparticle-Mediated Cancer Chemotherapy;Personalized and Precision Nanomedicine for Cancer Treatment;2024

5. Nanomedicine in cancer therapy;Signal Transduction and Targeted Therapy;2023-08-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3